SCPX
Scorpius Holdings, Inc.
Set alert
- YTD
- +200.00%
- 1 year
- -53.85%
- Open
- 0.01
- Prev close
- 0.0006
- Mkt cap
- 36.69K
- Vol
- 60.81K
- Avg vol
- 8.87K
- EPS
- -4.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.01
- High
- 0.0111
- Forward P/E
- -0.11
- Beta
- -0.33
- Short ratio
- 0.80
- Inst. own
- 19.08%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.6294
- 200-d avg
- 0.57885
- 1y target
- 5.00
Key statistics
- Market cap
- 1.34M
- Enterprise value
- 12.72M
- Trailing P/E
- 0.00
- Forward P/E
- -0.11
- PEG ratio
- 0.00
- Price / sales
- 0.14
- Price / book
- 0.00
- EPS (TTM)
- -1,901.49
- Beta
- -0.33
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 9.85M
- Revenue growth
- 15.50%
- Free cash flow
- -16.05M
- Total cash
- 1.51M
- Total debt
- 15.87M
- Return on equity
- -91.85%
- Shares outstanding
- 4.33M
- Short % of float
- 3.22%
- 50-day average
- 0.6294
- 200-day average
- 0.57885
Analyst view
Consensus: none
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 1, 2023 | Brookline Capital | down | Buy | Hold |
| Apr 3, 2023 | Maxim Group | down | Buy | Hold |
| Mar 3, 2021 | Cantor Fitzgerald | init | — | Overweight |
About Scorpius Holdings, Inc.
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- scorpiusbiologics.com
News
- Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission
- Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
- Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
- Crude Oil Gains 3%; 3M Posts Better-Than-Expected Q1 Results
- Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
- Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Scorpius Holdings Cancels Planned Reverse Stock Split
Your note
Sign in to keep a note on SCPX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| WOLF JEFFREY ALAN J.D. | Chief Executive Officer | Stock Award(Grant) | May 15, 2024 | 3,594,040 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sabby Management, LLC | 1.36% | 346,256 | 107.48K | Sep 29, 2024 |
| Warberg Asset Management LLC | 0.37% | 95,000 | 29.49K | Sep 29, 2024 |
| Altium Capital Management, LP | 0.35% | 88,291 | 27.41K | Sep 29, 2024 |
| HRT Financial LP | 0.20% | 51,601 | 16.02K | Sep 29, 2024 |
| UBS Group AG | 0.08% | 19,290 | 5.99K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.06% | 15,904 | 4.94K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.06% | 15,605 | 4.84K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.01% | 3,451 | 1.07K | Oct 30, 2024 |